Status and phase
Conditions
Treatments
About
Patients with Dent disease have suppressed levels of FGF 23 which contributes to hypercalciuria, kidney stones, nephrocalcinosis and renal failure. Supplementation with phosphorus may reduce hypercalciuria.
Enrollment
Sex
Volunteers
Inclusion criteria
Patients will be recruited from those in the RKSC Dent Registry
Diagnostic criteria for Dent disease Observational arm include:
Diagnostic criteria for Dent disease Intervention arm include:
Idiopathic calcium nephrolithiasis with renal phosphate leak
Idiopathic calcium nephrolithiasis without renal phosphate leak
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
30 participants in 3 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal